Chemours Q1 Loss of $29M, TSS Sales Rise 22% to $568M
Chemours reported a Q1 net loss of $29M ($0.19/share) on $1.38B revenue, missing the $1.4B consensus, while adjusted EPS of $0.05 and adjusted EBITDA rose 2% to $169M. Its Thermal & Specialized Solutions segment achieved record $568M sales (22% growth), with $287M Kuan Yin sale proceeds funding €140M debt reduction.
1. Q1 Financial Results
Chemours posted a net loss of $29M ($0.19 per share) in Q1 2026, compared with a $5M loss ($0.03 per share) in the prior-year quarter, on net sales of $1.38B, a 1% year-over-year increase that fell short of the $1.4B consensus. Adjusted net income was $8M ($0.05 per share) and adjusted EBITDA climbed to $169M from $166M a year earlier.
2. Thermal & Specialized Solutions
The Thermal & Specialized Solutions segment recorded a first-quarter net sales record of $568M, up 22% year-over-year on an 11% pricing boost and 9% volume gain driven by 12% growth in Opteon™ Refrigerants and a 67% surge in Freon™ sales. Adjusted EBITDA jumped 35% to $190M, lifting margins to 33%.
3. Titanium Technologies and APM Performance
Titanium Technologies net sales dropped 6% to $559M, with adjusted EBITDA declining 64% to $18M due to lower TiO2 pigment volumes. Advanced Performance Materials also saw volume constraints from an operational outage and softer cyclical end markets, partially offset by recent price increases.
4. Kuan Yin Sale and Debt Reduction
Chemours received approximately $287M in initial net proceeds from the sale of the Kuan Yin site and plans to deploy funds to retire €140M of outstanding debt, strengthening its balance sheet and enhancing liquidity for ongoing strategic initiatives.